Company Filing History:

9 out of 685

Academia Sinica

patents

4 out of 512

Sloan-kettering Institute for Cancer Research

patents

1 out of 181

National Health Research Institutes

patents

4. 1 out of 559

Memorial Sloan Kettering Cancer Center

patents

where one patent can have more than one assignee

Years Active: 1992-2021

Loading Chart...

14 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11066412 - Substituted pyrrolo[2,1-a]phthalazines and benzo[g]pyrrolo[2,1-a]phthalazines for the treatment of cancer (2021-07-20),

2. 10548861 - Use of ureidomustine (BO-1055) in cancer treatment (2020-02-04),

3. 9662324 - Methods and compositions for treating β-thalassemia and sickle cell disease (2017-05-30),

4. 9193687 - Phenyl N-mustard linked to DNA-affinic molecules or water-soluble aryl rings, method and their use as cancer therapeutic agents (2015-11-24),

5. 8772284 - Method of treating cancer using combination of a bifunctional alkylating agent and DNA repair inhibitors (2014-07-08),

6. 8703951 - Synthesis of 4H-benzo[D]pyrrolo[1,2-A]thiazoles and indolizino[6,7-b]indole derivatives and their use as antitumor therapeutic agents (2014-04-22),

7. 8410130 - Synthesis of 8H-3A-aza-cyclopenta [A ]indenes and 5,10-dihydropyrrolo[1,2-B]isoquinolines derivatives and their use as antitumor therapeutic agents (2013-04-02),

8. 8222297 - Aniline or phenol mustards linked to DNA-affinic molecules or water-soluble aromatic rings and their use as cancer therapeutic agents (2012-07-17),

9. 6821983 - 5-(9-acridinylamino)-toluidine compounds (2004-11-23),

10. 5939428 - Alkyl N-�3-(acridin-9-yl)amino-5-hydroxymethyl! phenylcarbamates (1999-08-17),

11. 5476952 - Antitumor cyclopentnaphthoquinone and cyclopentanthraquinone derivatives (1995-12-19),

12. 5354864 - 3-(9-acridinylamino)-5-hydroxymethylaniline derivatives as anticancer (1994-10-11),

13. 5296602 - Multisubstituted 1-hydroxy-9-acridones with anticancer activity (1994-03-22),

14. 5112869 - Substituted 1-phenylnaphthalenes (1992-05-12),

Title: Tsann-Long Su: Pioneering Innovator in Cancer Treatment

Introduction:

Tsann-Long Su is a distinguished inventor hailing from New Taipei, Taiwan, with a remarkable portfolio of 14 patents. His unwavering commitment to innovation and excellence has earned him the status of a visionary in the realm of technology and healthcare.

Latest Patents:

Su's recent groundbreaking patents include "Substituted pyrrolo[2,1-a]phthalazines and benzo[g]pyrrolo[2,1-a]phthalazines for the treatment of cancer." These novel bifunctional compounds show promising potential in the treatment and prophylaxis of various cancers. Another notable patent is the use of ureidomustine (BO-1055) in cancer treatment, demonstrating his profound impact on advancing cancer therapies.

Career Highlights:

Having worked at esteemed institutions such as Academia Sinica and the Sloan-Kettering Institute for Cancer Research, Tsann-Long Su has been at the forefront of cutting-edge research in the field of oncology. His innovative spirit and dedication to improving cancer treatment have marked him as a trailblazer in the industry.

Collaborations:

Throughout his career, Tsann-Long Su has collaborated with esteemed colleagues like Ting-Chao Chou and Kyoichi A. Watanabe. These partnerships have led to significant advancements in cancer research and the development of novel treatment strategies, further solidifying Su's reputation as a collaborative and forward-thinking inventor.

Conclusion:

In conclusion, Tsann-Long Su's passion for innovation and his relentless pursuit of excellence have positioned him as a leading figure in the field of cancer treatment. His remarkable patents and career achievements underscore his significant contributions to science and healthcare, inspiring future generations of inventors and innovators to push the boundaries of possibility in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.